FrancophonIA/ELRC3.0 huggingface dataset:
English: Myelosuppression (see section 4.4) with fatal outcome has been reported following administration of etoposide phosphate.
Croatian: Mijelosupresija (vidjeti dio 4.4) sa smrtnim ishodom prijavljena je nakon primjene etopozidfosfata.
English: The content of each injection vial of ETOPOPHOS and associated names 1000 mg has to be diluted in 100 ml of:
Croatian: Sadržaj svake bočice injekcije ETOPOPHOSA i pridruženih imena 1000 mg mora se otopiti u 100 ml:
English: Preparation of ETOPOPHOS and associated names 100 mg powder for solution for infusion Before use the content of each vial must be reconstituted with 5 ml or 10 ml of:
Croatian: Priprema lijeka ETOPOPHOS i pridružena imena 100 mg prašak za otopinu za infuziju Prije primjene, sadržaj svake bočice mora se rekonstituirati s 5 ml ili 10 ml:
English: In patients with creatinine clearance less than 15 mL/min and on dialysis further dose reduction is likely to be required as etoposide clearance is further reduced in these patients (see section 4.4).
Croatian: Kod bolesnika s klirensom kreatinina nižim od 15 ml/min i koji su na dijalizi, vjerojatno će biti potrebno dodatno sniženje doze jer kod tih bolesnika dolazi do daljnjeg sniženja klirensa etopozida (vidjeti dio 4.4).
English: ETOPOPHOS and associated names should be given only by slow intravenous infusion (usually over a 30 to 60 minute period) since hypotension has been reported as a possible side effect of rapid intravenous injection.
Croatian: ETOPOPHOS i pridružena imena smije se davati samo sporom intravenskom infuzijom (obično u trajanju od 30 do 60 minuta), jer je hipotenzija prijavljena kao moguća nuspojava brze intravenske injekcije.
English: Respiratory, thoracic and mediastinal disorders rare interstitial pneumonitis, pulmonary fibrosis not known bronchospasm
Croatian: Poremećaji dišnog sustava, prsišta i sredoprsja rijetko intersticijski pneumonitis, plućna fibroza nepoznato bronhospazam
English: Effects of other drugs on the pharmacokinetics of etoposide phosphate
Croatian: Učinci drugih lijekova na farmakokinetiku etopozidfosfata
English: - testicular cancer - small cell lung cancer - cancer of the blood (acute myeloid leukaemia) - tumour in the lymphatic system (Hodgkin's lymphoma, non-Hodgkin's lymphoma) - reproductive system cancers (gestational trophoblastic neoplasia and ovarian cancer)
Croatian: - rak testisa - rak pluća malih stanica - rak krvi (akutna mijeloična leukemija) - tumor limfnog sustava (Hodgkinov limfom, non-Hodgkinov limfom) - vrste raka reproduktivnog sustava (gestacijska trofoblastična neoplazija i rak jajnika)
English: ETOPOPHOS and associated names is for single use only.
Croatian: ETOPOPHOS i pridružena imena namijenjeni su samo za jednokratnu primjenu.
English: The following haematological parameters should be measured at the start of therapy and prior to each subsequent dose of ETOPOPHOS and associated names: platelet count, haemoglobin, white blood cell count and differential.
Croatian: Na početku terapije i prije svake sljedeće doze ETOPOPHOSA i pridruženih imena treba izmjeriti sljedeće hematološke parametre: broj trombocita, hemoglobin, broj leukocita i diferencijalnu krvnu sliku.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial Label (100 mg)
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE Naljepnica na bočici (100 mg)
English: ETOPOPHOS and associated names is administered by slow intravenous infusion (usually over a 30 to 60 minute period) since hypotension has been reported as a possible side effect of rapid intravenous injection.
Croatian: ETOPOPHOS i pridružena imena primjenjuje se sporom intravenskom infuzijom (obično u trajanju od 30 do 60 minuta) budući da je hipotenzija prijavljena kao moguća nuspojava brze intravenske injekcije.
English: Tumour lysis syndrome (sometimes fatal) has been reported following the use of etoposide phosphate in association with other chemotherapeutic drugs (see section 4.4).
Croatian: Sindrom lize tumora (ponekad sa smrtnim ishodom) zabilježen je nakon primjene etopozidfosfata s drugim kemoterapeuticima (vidjeti dio 4.4).
English: As with other potentially toxic compounds, caution should be exercised in handling and preparing ETOPOPHOS and associated names solutions.
Croatian: Kao i s drugim potencijalno toksičnim spojevima, potrebno je postupati s oprezom kod rukovanja i pripreme otopine ETOPOPHOSA i pridruženih imena.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Vial Label (1000 mg)
Croatian: PODACI KOJE MORA NAJMANJE SADRŽAVATI MALO UNUTARNJE PAKIRANJE Naljepnica na bočici (1000 mg)
English: Administration Precautions: As with other potentially toxic compounds, caution should be exercised in handling and preparing the solution of ETOPOPHOS and associated names.
Croatian: Mjere opreza kod primjene: Kao i s drugim potencijalno toksičnim spojevima, potreban je oprez kod rukovanja i pripreme otopine ETOPOPHOSA i pridruženih imena.
English: *Myelosuppression with fatal outcome has been reported **Anaphylactic reactions can be fatal ***Seizure is occasionally associated with allergic reactions.
Croatian: *Prijavljena je mijelosupresija sa smrtnim ishodom **Anafilaktičke reakcije mogu biti smrtonosne
English: Gestational trophoblastic neoplasia
Croatian: Gestacijska trofoblastična neoplazija
English: Dosage should be modified to take into account the myelosuppressive effects of other drugs in the combination or the effects of prior radiation therapy or chemotherapy which may have compromised bone marrow reserve.
Croatian: Dozu treba modificirati kako bi se uzeli u obzir mijelosupresivni učinci drugih lijekova u kombinaciji ili učinci prethodne radioterapije ili kemoterapije koji su mogli oštetiti rezervu koštane srži.
English: If ETOPOPHOS and associated names solution contacts the skin or mucosa, immediately wash the skin with soap and water and flush the mucosa with water (see section 6.6).
Croatian: U slučaju kontakta ETOPHOSA i pridruženih imena s kožom ili sluznicom, odmah operite kožu sapunom i vodom i isperite sluznicu vodom (vidjeti dio 6.6).
English: Anaphylactic reactions can occur with the initial dose of etoposide phosphate.
Croatian: Anafilaktičke reakcije mogu se pojaviti kod prve doze etopozidfosfata
English: Etoposide has been shown to cause metaphase arrest in chick fibroblasts.
Croatian: Pokazalo se da etopozid izaziva zastoj diobe pilećih fibroblasta u metafazi.
English: ETOPOPHOS and associated names in paediatric patients has been used in the range of 75 to 150 mg/m2/day (etoposide equivalent) for 2 to 5 days in combination with other antineoplastic agents.
Croatian: ETOPOPHOS i pridružena imena u pedijatrijskih se bolesnika primjenjuje u rasponu od 75 do 150 mg/m2/dan (ekvivalent etopozida) tijekom 2 do 5 dana u kombinaciji s drugim antineoplasticima.
English: ETOPOPHOS and associated names should only be administered and monitored under the supervision of a qualified physician experienced in the use of anti-neoplastic medicinal products (see section 4.4).
Croatian: Liječenje lijekom ETOPOPHOS i pridružena imena smije se započeti i provoditi samo pod nadzorom kvalificiranog liječnika iskusnog u primjeni antineoplastičnih lijekova (vidjeti dio 4.4).
English: What ETOPOPHOS and associated names looks like and contents of the pack
Croatian: Kako ETOPOPHOS i pridružena imena izgleda i sadržaj pakiranja
English: This will yield a reconstituted stock solution containing 10 mg/ml etoposide.
Croatian: To će dati zalihu rekonstituirane otopine koja sadrži 10 mg/ml etopozida.
English: Subsequent dosing should be based on patient tolerance and clinical effect.
Croatian: Daljnje doze treba temeljiti na podnošljivosti i kliničkom učinku u pojedinog bolesnika.
English: - cancer of the blood (acute myeloid leukaemia) - tumour in the lymphatic system (Hodgkin's lymphoma, non-Hodgkin's lymphoma)
Croatian: - rak krvi (akutna mijeloična leukemija) - tumor limfnog sustava (Hodgkinov limfom, non-Hodgkinov limfom)
English: In patients with creatinine clearance less than 15 mL/min and on dialysis further dose reduction should be considered.
Croatian: U bolesnika s klirensom kreatinina nižim od 15 ml/min i koji su na dijalizi, treba razmotriti daljnje smanjenje doze.
English: What ETOPOPHOS and associated names is and what it is used for
Croatian: Što je ETOPOPHOS i pridružena imena i za što se koristi
English: - The active substance is etoposide phophate.
Croatian: - Djelatna tvar je etopozidfosfat.
English: ETOPOPHOS and associated names is used in the treatment of certain types of cancers in adults:
Croatian: ETOPOPHOS i pridružena imena koristi se u liječenju određenih vrsta raka u odraslih:
English: ETOPOPHOS and associated names is used in the treatment of certain types of cancers in children:
Croatian: ETOPOPHOS i pridružena imena koristi se u liječenju određenih vrsta raka u djece:
English: The role that concentration or rate of infusion plays in the development of anaphylactic reactions is uncertain.
Croatian: Nije pouzdano utvrđena uloga koju u razvoju anafilaktičke reakcije igra koncentracija ili brzina davanja infuzije.
English: ETOPOPHOS and associated names should be terminated immediately, followed by the administration of pressor agents, corticosteroids, antihistamines, or volume expanders at the discretion of the physician.
Croatian: Odmah treba prekinuti primjenu ETOPOPHOSA i pridruženih imena i nakon toga primijeniti presorne lijekove, kortikosteroide, antihistaminike ili ekspandere volumena, prema odluci liječnika.
English: Granulocyte and platelet nadirs tend to occur about 10 to14 days after administration of etoposide phosphate depending on the way of administration and treatment scheme.
Croatian: Najniže vrijednosti broja granulocita i trombocita javljaju se za 10 do 14 dana nakon primjene etopozidfosfata, ovisno o putu primjene i terapijskoj shemi.
English: When restarting the infusion, a slower administration rate should be used.
Croatian: Kod ponovnog započinjanja infuzije, treba je davati manjom brzinom.
English: Injection site reactions may occur during administration of ETOPOPHOS and associated names.
Croatian: Reakcije na mjestu injekcije mogu se pojaviti za vrijeme primjene ETOPOPHOSA i pridruženih imena.
English: OUTER CARTON LABEL TEXT
Croatian: TEKST OZNAČIVANJA KUTIJE
English: • increased liver enzymes
Croatian: • povišene vrijednosti jetrenih enzima • povišeni bilirubin
English: What ETOPOPHOS and associated names contains
Croatian: Što ETOPOPHOS i pridružena imena sadrži
English: In the paragraphs below the incidences of adverse events, given as the mean percent, are derived from studies that utilized single agent ETOPOPHOS and associated names therapy.
Croatian: U sljedećim odlomcima, incidencija nuspojava prikazana kao srednji postotak, dobivena je iz ispitivanja u kojima se ETOPOPHOS i pridružena imena koristio kao monoterapija.
English: If any discolouration or particulate matter is observed, the reconstituted solution must be discarded.
Croatian: Ukoliko se uoči promjena boje ili prisutnost čestica, rekonstituirana otopina mora se baciti.
English: Vascular disorders common hypertension, transient systolic hypotension following rapid intravenous administration uncommon haemorrhage
Croatian: Krvožilni poremećaji često hipertenzija, prolazna sistolička hipotenzija nakon brze intravenske primjene manje često krvarenje
English: • difficulty breathing
Croatian: • neplodnost • otežano disanje
English: In vitro, etoposide is highly protein bound (97%) to human plasma proteins.
Croatian: In vitro, etopozid je velikim dijelom vezan za proteine ljudske plazme
English: Preparation of ETOPOPHOS and associated names 1000 mg powder for solution for infusion
Croatian: Priprema lijeka ETOPOPHOS i pridružena imena 1000 mg prašak za otopinu za infuziju
English: Each vial contains etoposide phosphate equivalent to etoposide 100 mg or 1000 mg as the active ingredient.
Croatian: Jedna bočica sadrži etopozidfosfat koji odgovara etopozidu od 100 mg ili 1000 mg kao djelatnoj tvari.
English: Each vial contains 1136 mg etoposide phosphate equivalent to 1000 mg etoposide.
Croatian: Jedna bočica sadrži 1136 mg etopozidfosfata, što odgovara 1000 mg etopozida.
English: Only use clear solutions.
Croatian: Smiju se koristiti samo bistre otopine.
English: ETOPOPHOS and associated names should only be administered and monitored under the supervision of a qualified physician experienced in the use of anti-neoplastic medicinal products.
Croatian: Liječenje ETOPOPHOSOM i pridruženim imenima smije se započeti i provoditi samo pod nadzorom kvalificiranog liječnika iskusnog u primjeni antineoplastičnih lijekova.
English: Preparation of Intravenous Solution
Croatian: Priprema intravenske otopine
English: - If you are allergic to etoposide or any of the other ingredients of this medicine (listed in section
Croatian: Nemojte primati ETOPOPHOS i pridružena imena - ako ste alergični na etopozid ili bilo koji drugi sastojak ovog lijeka (naveden u dijelu 6).
English: ETOPOPHOS and associated names is indicated for first line and second line therapy in combination with other approved chemotherapeutic agents for the treatment of high risk gestational trophoblastic neoplasia in adults.
Croatian: ETOPOPHOS i pridružena imena indiciran je za prvu liniju i drugu liniju terapije u kombinaciji s drugim odobrenim kemoterapeuticima za liječenje gestacijske trofoblastične neoplazije visokog rizika u odraslih.
English: The resulting stock solution may be administered without further dilution or can be further diluted with 5% glucose solution or 0.9% sodium chloride solution to a final concentration of 0.1 mg/ml etoposide.
Croatian: Dobivena rekonstituirana otopina se može primijeniti bez dodatnog razrjeđivanja ili se može dodatno razrijediti 5%-tnom otopinom glukoze ili 0,9%-tnom otopinom natrijevog klorida, do konačne koncentracije od 0,1 mg/ml etopozida.
English: Possible side effects experienced with ETOPOPHOS and associated names that are;
Croatian: Moguće nuspojave kod primjene ETOPOPHOSA i pridruženih imena su;
English: If etoposide phosphate should contact the skin or mucosa, immediately wash the skin with soap and water and flush the mucosa with water.
Croatian: U slučaju kontakta etopozidfosfata s kožom ili sluznicama, odmah operite kožu sapunom i vodom i isperite sluznicu vodom.
English: ETOPOPHOS and associated names is indicated for the treatment of platinum-resistant/refractory epithelial ovarian cancer in adults.
Croatian: ETOPOPHOS i pridružena imena indiciran je za liječenje rezistentnog na platinu/refraktornog epitelnog raka jajnika u odraslih.
English: How to store ETOPOPHOS and associated names
Croatian: Kako čuvati ETOPOPHOS i pridružena imena
English: After reconstitution, the solution can be administered without further dilution or it can be further diluted with 5% glucose solution or 0.9% sodium chloride solution to obtain concentrations as low as 0.1 mg/ml etoposide.
Croatian: Otopina se nakon rekonstitucije može primijeniti bez dodatnog razrjeđivanja ili se može dodatno razrijediti 5%-tnom otopinom glukoze ili 0,9%-tnom otopinom natrijevog klorida, kako bi se postigle koncentracije od najmanje 0,1 mg/ml etopozida.
English: Skin reactions associated with accidental exposure to ETOPOPHOS and associated names may occur.
Croatian: Mogu se pojaviti kožne reakcije povezane sa slučajnim izlaganjem ETOPOPHOSU i pridruženim imenima.
English: If ETOPOPHOS and associated names solution contacts the skin or mucosa, immediately wash the skin with soap and water and flush the mucosa with water.
Croatian: U slučaju kontakta ETOPHOSA i pridruženih imena s kožom ili sluznicom, odmah operite kožu sapunom i vodom i isperite sluznicu vodom.
English: ETOPOPHOS and associated names is indicated in combination with other approved chemotherapeutic agents for the treatment of first line, recurrent or refractory testicular cancer in adults.
Croatian: ETOPOPHOS i pridružena imena indiciran je u kombinaciji s drugim odobrenim kemoterapeuticima za prvu liniju liječenja, za liječenje recidiva ili refraktornog raka testisa u odraslih.
English: The usual dose, based on etoposide, is 50 to100mg/m2 body surface area, daily for 5 days in a row or 100 to 120 mg/ m2 body surface area on days 1, 3 and 5.
Croatian: temeljena na etopozidu, je 50 do 100 mg/m2 površine tijela na dan primijenjena tijekom 5 uzastopnih dana ili 100 do 120 mg/m2 površine tijela na dan primijenjena 1., 3. i 5. dana.
English: The mechanism of action of etoposide phosphate is considered to be the same as that of etoposide.
Croatian: Smatra se da etopozidfosfat ima isti mehanizam djelovanja kao etopozid.
English: Nadirs tend to occur earlier with intravenous administration compared to oral administration.
Croatian: Najniže vrijednosti se ranije javljaju kod intravenske primjene u usporedbi s peroralnom primjenom.
English: The recommended dose of ETOPOPHOS and associated names is 50 to 100 mg/m2/day (etoposide equivalent) on days 1 to 5 or 100 to 120 mg/m2 on days 1, 3, and 5 every 3 to 4 weeks in combination with other drugs indicated in the disease to be treated.
Croatian: Preporučena doza ETOPOPHOSA i pridruženih imena je 50 do 100 mg/m2/dan (ekvivalent etopozida) od 1. do 5. dana ili 100 do 120 mg/m2 primijenjeno 1., 3. i 5. dana svaka 3 do 4 tjedna, u kombinaciji s drugim lijekovima odobrenima za liječenje te bolesti.
English: Gastrointestinal disorders very common abdominal pain, anorexia, constipation, nausea and vomiting common diarrhoea, mucositis (including stomatitis and esophagitis)
Croatian: konstipacija, mučnina i povraćanje često proljev, mukozitis (uključujući stomatitis i ezofagitis)
English: How you will be given ETOPOPHOS and associated names
Croatian: Kako ćete primati ETOPOPHOS i pridružena imena
English: The products administered by parenteral route must be visually examined to check for any particulates or discoloration prior to administration.
Croatian: Lijekovi koji se primjenjuju parenteralnim putem, prije primjene moraju se vizualno provjeriti zbog prisutnosti čestica ili promjene boje.
English: infections, or at a thrombocyte count below 25,000 cells/mm3, which is not caused by the disease.
Croatian: Osim toga, dozu treba prilagoditi kod pojave vrućice, infekcija ili ako je broj trombocita manji od 25 000 stanica/mm3, što nije uzrokovano bolešću.
English: ETOPOPHOS and associated names contains
Croatian: ETOPHOS i pridružena imena sadrži
English: You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine.
Croatian: Nuspojave možete prijaviti i izravno putem nacionalnog sustava za prijavu nuspojava: navedenog u Dodatku V.
English: 56% (45% of the dose was excreted as etoposide) and faecal recovery of radioactivity was 44% of the adminitered dose at 120 hours.
Croatian: Nakon intravenske primjene 14C-etopozida (100 do 124 mg/m2), prosječna pronađena radioaktivnost u mokraći iznosila je 56% (45% doze se izlučilo u obliku etopozida) i pronađena radioaktivnost u stolici iznosila je 44% primijenjene doze nakon 120 sati.
English: Dose of Etoposide Phosphate
Croatian: Doza etopozidfosfata
English: Etoposide (as phosphate)
Croatian: Nuspojava (pojmovi po MedDRA-i)
English: General disorders and administration site conditions very common asthenia, malaise common extravasation****, phlebitis rare pyrexia
Croatian: Opći poremećaji i reakcije na mjestu primjene vrlo često astenija, malaksalost često ekstravazacija****, flebitis rijetko pireksija
English: Immune system disorders common anaphylactic reactions** not known angioedema, bronchospasm Metabolism and nutrition disorders not known tumour lysis syndrome
Croatian: nepoznato angioedem, bronhospazam Poremećaji metabolizma i prehrane nepoznato sindrom lize tumora
English: • face and tongue swelling
Croatian: • oticanje lica i jezika Prijavljivanje nuspojava
English: ETOPOPHOS and associated names should not be administered to patients with neutrophil counts less than 1,500 cells/mm3
Croatian: ETOPOPHOS i pridružena imena ne smiju se primjenjivati bolesnicima čiji je broj neutrofila manji od 1500 stanica/mm3 ili je broj trombocita manji od 100 000 stanica/mm3, osim ako je to uzrokovano malignom bolešću.
English: There is the potential for serious adverse reactions in nursing infants from ETOPOPHOS and associated names.
Croatian: Postoji mogućnost ozbiljnih nuspojava ETOPOPHOSA i pridruženih imena kod dojenčadi.
English: Nausea and vomiting are the major gastrointestinal toxicities of etoposide phosphate.
Croatian: Glavne gastrointestinalne toksičnosti etopozidfosfata su mučnina i povraćanje.
English: ETOPOPHOS and associated names (see Annex I) 100 mg powder for solution for infusion ETOPOPHOS and associated names (see Annex I) 1000 mg powder for solution for infusion
Croatian: ETOPOPHOS i pridružena imena (vidjeti Prilog I.) 100 mg prašak za otopinu za infuziju ETOPOPHOS i pridružena imena (vidjeti Prilog I.) 1000 mg prašak za otopinu za infuziju etopozidfosfat
English: Uncommon side effects (affecting between 1 in 100 and 1 in 1000 people) • tingling or numbness in hands and feet
Croatian: Česte nuspojave (mogu se javiti kod između 1 na 10 i 1 na 100 osoba) • akutna leukemija
English: ETOPOPHOS and associated names is indicated in combination with other approved chemotherapeutic agents for the treatment of acute myeloid leukaemia in adult and paediatric patients.
Croatian: ETOPOPHOS i pridružena imena indiciran je u kombinaciji s drugim odobrenim kemoterapeuticima za liječenje akutne mijeloične leukemije u odraslih i pedijatrijskih bolesnika.
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each vial contains etoposide 100 mg (as phosphate) Each vial contains etoposide 1000 mg (as phosphate)
Croatian: Jedna bočica sadrži 100 mg etopozida (u obliku etopozidfosfata) Jedna bočica sadrži 1000 mg etopozida (u obliku etopozidfosfata)
English: • sleepiness or tiredness
Croatian: • trnci ili utrnulost šaka i stopala
English: ETOPOPHOS and associated names is indicated in combination with other approved chemotherapeutic agents for the treatment of small-cell lung cancer in adults.
Croatian: ETOPOPHOS i pridružena imena indiciran je u kombinaciji s drugim odobrenim kemoterapeuticima za liječenje raka pluća malih stanica u odraslih.
English: ETOPOPHOS and associated names is indicated in combination with other approved chemotherapeutic agents for the treatment of non-Hodgkin's lymphoma in adult and paediatric patients.
Croatian: ETOPOPHOS i pridružena imena indiciran je u kombinaciji s drugim odobrenim kemoterapeuticima za liječenje non-Hodgkinovog limfoma u odraslih i pedijatrijskih bolesnika.
English: Date
Croatian: Serija
English: Dose limiting bone marrow suppression is the most significant toxicity associated with ETOPOPHOS and associated names therapy.
Croatian: Najznačajnija toksičnost povezana s terapijom ETOPOPHOSOM i pridruženim imenima je supresija koštane srži koja ograničava dozu.
English: ETOPOPHOS and associated names is indicated in combination with other approved chemotherapeutic agents for the treatment of Hodgkin's lymphoma in adult and paediatric patients.
Croatian: ETOPOPHOS i pridružena imena indiciran je u kombinaciji s drugim odobrenim kemoterapeuticima za liječenje Hodgkinovog limfoma u odraslih i pedijatrijskih bolesnika.
English: • jaundice (increased bilirubin) Common side effects (affecting between 1 in 10 and 1 in 100 people)
Croatian: • infekcija Manje česte pojave (mogu se javiti kod između 1 na 100 i 1 na 1000 osoba)
English: The following adverse reactions were reported from ETOPOPHOS and associated names clinical studies and post-marketing experience.
Croatian: U kliničkim ispitivanjima i nakon stavljanja lijeka u promet, prijavljene su sljedeće nuspojave ETOPOHOPOSA i pridruženih imena.
English: NAME OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION ETOPOPHOS and associated names 100 mg powder for solution for infusion [See Annex I - To be completed nationally]
Croatian: NAZIV LIJEKA I PUT(EVI) PRIMJENE LIJEKA ETOPOPHOS i pridružena imena 100 mg prašak za otopinu za infuziju [Vidjeti Prilog I.